The Nepean Blue Mountains Family Metabolic Health Service is conducting a research trial to investigate potential new treatments for those who are overweight or people with obesity.
The SYNCHRONIZE-2 trial is testing whether an investigational medication can help reduce body weight and improve blood sugar levels in people with type 2 diabetes.
It is hoped the medication may help to treat and manage overweight or obesity by causing a feeling of fullness, increasing energy use by the body, slowing the movement of food through the digestive tract, and lowering blood sugar levels.
Treating overweight and obesity can help prevent weight-related conditions such as type 2 diabetes mellitus, sleep apnoea and heart or liver disease.
You, or someone you know, may be able to take part in the study if you/they:
- are 18 years of age or older;
- have a body mass index of 27kg/m2Â or more (overweight or people with obesity);
- have been diagnosed with type 2 diabetes mellitus for at least 6 months;
- have made at least 1 attempt to lose weight through nutrition and physical activity, but did not meet your/their goal.
They may also be additional requirements to be able to take part.
Call 4734 4533 or email NBMLHD-FamilyMetabolicHealthService@health.nsw.gov.au for further information and to discuss your eligibility.
You may be eligible for reimbursement of your time and travel. Please discuss this with the team for details.
The trial has been approved by review boards which have been formally designated to protect the rights, safety and wellbeing of participants.
